Market Access Matters – Details, episodes & analysis

In this episode we're joined by our first guest from Biotech - Ning Lu, who is Associate Director, International Pricing & Market Access at Blueprint Medicines.

Ning shares her views on the complexities of market access and what makes the Biotech industry unique. She shares what inspired her to pursue a career in market access in biotechnology and why she feels it's a dynamic role and opportunity to 'connect the dots' with everything you learn.   

Ning references and recommends the book "Science Business: The promise. The reality. And the future of biotech." By Gary Pisano. More information on this title is available here. https://amzn.eu/d/5nfsQVA  

The opinions shared in this episode are Ning’s own views and not representative of the organisation she is working for.  

Send us a text

There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function. In this episode, Marco Rauland from Merck KGaA joins us to explore this topic.

Marco is Vice President Global Market Access and Pricing strategy, Pricing and Analytics. With over 25 years' experience in the field, he shares his views on the importance of clear communication when engaging all stakeholders and why MA&P leaders need to take a holistic approach to understanding all corners of drug development and launch. 

We also touch on the potential for AI in market access as the industry begins to explore the use cases of this latest innovation. Plus, the challenges market access leaders are facing and what strategies can help them overcome them.  

The opinions shared in this episode are Marco’s own views and not representative of the organisation he is working for.  

Send us a text

In this episode Louise teams up with Access Infinity Partner, Nick Proctor. Nick has been a consultant in the biopharmaceutical industry for over twenty years and shares his views on the hot topics and trends which he feels will have the biggest impact on market access in the coming years, also offering his insights on the themes which are 'hype'. 
Throughout his career Nick has also been responsible for training, coaching and mentoring others in global market access and pricing, and talks to Louise about his passion for empowering aspiring market access leaders on their own professional growth journeys.  

Send us a text

Welcome back to the Market Access Matters podcast! In the first episode of series 2, Louise interviews David McConkey, Virology and Oncology Global Value and Access Director at Gilead Services. 
Having started his career in consulting and then working across global and country roles, David has a breadth of experience in market access. 
In this discussion he shares his experiences of taking on new challenges, leading teams into new territories and what he's learnt along the way.  

The opinions shared in this episode are David's own views and not those of the company he is working for.

Send us a text

In this episode we’re joined by Katie Gardner, who is Head of Global Market Access Excellence at Astellas. We hear Katie’s insights on the changing landscape of market access and what it demands from teams in terms of agility and innovation. She talks about how digital technology can empower teams to evolve with the ever-changing demands of the market and what her team are doing to drive market access excellence. 

Katie is passionate about building high performing teams and discusses the role of mindset within this. It’s a fascinating discussion with valuable insights and advice shared, especially for market access professionals striving for professional growth.

The opinions shared in this podcast are Katie's own views.  

Send us a text

In this episode we're joined by Pfizer's Director Global Market Access for Medical Dermatology, Séverine Baquart. Séverine's career spans over twenty years at Pfizer, where she's seen significant change including the separation of the market access and pricing function from regulatory affairs. In this conversation, Séverine shares what she loves most about market access, the innovations she's seen and her aspirations for the future of market access on a global scale.

The opinions shared in this podcast are Séverine's own views.  

Send us a text

Shravani Madishetti is Access Infinity's APAC Pricing and Market Access Lead. Before taking on this role, Shravani specialised in pricing and market access for Novartis, where she was based for over seven years. She now leads a team that supports data functionality for our digital solutions, Access Hub and Nuro.
In this episode, we discuss Shravani's unique perspective on market access and why it provides a rewarding career path. 

Send us a text

In this episode we're joined by Paula Albuquerque, who is Director Global Market Access Immuno - Rheumatology at UCB. Paula has a comprehensive global background within the healthcare, pharmaceutical, biotech and management consulting sectors and has a strong focus on how to translate science into commercial value propositions.
Paula discusses her purpose: bringing to market and launching new medicines in the way that considers the needs and realities of the patients and health systems. She also reflects on key takeaways from the global launches she's been involved in, and shares what she's doing to prepare for the future of market access. 

The opinions shared in this podcast are Paula's own views.  

Send us a text

In this episode, Louise interviews Access Infinity's Client Success Manager Cloë Carey. Cloë and her surrounding team are pioneering digital transformation in pharma and specifically, market access. 
They discuss Cloë's natural interest in science when she was young and how this influenced her career path. Cloë also shares what it is about market access that keeps her engaged and excited as well as what she's learnt along the way.  

Send us a text

In this episode Louise is joined by Ana Plata, Global Pricing Head - BioPharmaceuticals at AstraZeneca. 
Ana specialises in strategic pricing and market access to support pharmaceutical life cycles and discusses her career journey to date, which has included working across both industry and consulting. 
Ana has a clear passion for developing and leading teams. She shares her views on the importance of supporting people to grow, the power of connecting with peers and the value of mentors and coaching to support career journeys and growth, which by her own admission, is rarely a linear path. 

Send us a text